CLINICAL_TRIALS trial_result · 2024-07-03

Clinical Trial Update: Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations [Phase 2]

A Phase 2 study evaluating CVN424 in Parkinson disease patients with motor fluctuations has completed, with results posted in July 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Cerevance Beta, Inc. | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-07-03